Homocysteine
Names | |
---|---|
IUPAC name
2-Amino-4-sulfanylbutanoic acid
| |
Identifiers | |
3D model (
JSmol ) |
|
ChEBI | |
ChEMBL | |
ChemSpider | |
ECHA InfoCard
|
100.006.567 |
EC Number |
|
KEGG | |
PubChem CID
|
|
UNII |
|
| |
| |
Properties | |
C4H9NO2S | |
Molar mass | 135.18 g/mol |
Appearance | White crystalline powder |
Melting point | 234–235 °C (453–455 °F; 507–508 K)[2] (decomposes) |
soluble | |
log P | -2.56 [1] |
Acidity (pKa) | 2.25 [1] |
Hazards | |
GHS labelling: | |
Warning | |
H302 | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Homocysteine (
High levels of homocysteine in the blood (
Hyperhomocysteinemia has been correlated with the occurrence of blood clots, heart attacks, and strokes, although it is unclear whether hyperhomocysteinemia is an independent risk factor for these conditions.
Structure
Homocysteine exists at neutral pH values as a zwitterion.
Biosynthesis and biochemical roles
Homocysteine is biosynthesized naturally via a multi-step process.
Biosynthesis of cysteine
Mammals biosynthesize the amino acid cysteine via homocysteine.
Methionine salvage
Homocysteine can be recycled into
Other reactions of biochemical significance
Homocysteine can cyclize to give
Homocysteine also acts as an allosteric antagonist at Dopamine D2 receptors.[13]
It has been proposed that both homocysteine and its thiolactone may have played a significant role in the appearance of life on the early Earth.[14]
Homocysteine levels
Homocysteine levels typically are higher in men than women, and increase with age.[15][16]
Common levels in Western populations are 10 to 12 μmol/L, and levels of 20 μmol/L are found in populations with low B-vitamin intakes or in the elderly (e.g., Rotterdam, Framingham).[17][18]
It is decreased with methyl folate trapping, where it is accompanied by decreased methylmalonic acid, increased folate, and a decrease in formiminoglutamic acid.[19] This is the opposite of MTHFR C677T mutations, which result in an increase in homocysteine.[citation needed]
Sex | Age | Lower limit | Upper limit | Unit | Elevated | Therapeutic target
|
Female | 12–19 years | 3.3[20] | 7.2[20] | μmol/L | > 10.4 μmol/L or > 140 μg/dl |
< 6.3 μmol/L[21] or < 85 μg/dL[21] |
45[22] | 100[22] | μg/dL | ||||
>60 years | 4.9[20] | 11.6[20] | μmol/L | |||
66[22] | 160[22] | μg/dL | ||||
Male | 12–19 years | 4.3[20] | 9.9[20] | μmol/L | > 11.4 μmol/L or > 150 μg/dL | |
60[22] | 130[22] | μg/dL | ||||
>60 years | 5.9[20] | 15.3[20] | μmol/L | |||
80[22] | 210[22] | μg/dL |
The ranges above are provided as examples only; test results always should be interpreted using the range provided by the laboratory that produced the result.
Elevated homocysteine
Abnormally high levels of homocysteine in the serum, above 15 μmol/L, are a medical condition called hyperhomocysteinemia.[23] This has been claimed to be a significant risk factor for the development of a wide range of diseases, including thrombosis,[24] neuropsychiatric illness,[25][26][27][28] and fractures.[29][30] It also is found to be associated with microalbuminuria, which is a strong indicator of the risk of future cardiovascular disease and renal dysfunction.[31] Vitamin B12 deficiency, when coupled with high serum folate levels, has been found to increase overall homocysteine concentrations as well.[32]
Typically, hyperhomocysteinemia is managed with vitamin B6, vitamin B9, and vitamin B12 supplementation.[33] However, supplementation with these vitamins does not appear to improve cardiovascular disease outcomes.[34]
References
- ^ PMID 19275147.
- .
- ^ "Homocysteine" (PDF). moh.gov.vn. Retrieved 5 April 2023.
- S2CID 3986295.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link - ^ Boudi, Brian F. "Noncoronary Atherosclerosis". Medscape. Archived from the original on 2013-05-11.
- ^ Homocysteine: The Facts, Tufts Health and Nutrition Letter, July 31, 2020 update
- S2CID 26125655.
- ^ van der Put NJ et al Folate, Homocysteine and Neural Tube Defects: An Overview Archived 2015-09-16 at the Wayback Machine Exp Biol Med (Maywood) April 2001 vol. 226 no. 4 243-270
- S2CID 2335090.
- ^ Champe, PC and Harvey, RA. "Biochemistry. Lippincott's Illustrated Reviews" 4th ed. Lippincott Williams and Wilkins, 2008
- ISBN 1-57259-153-6.
- PMID 20080717.
- (PDF) from the original on 2017-08-09.
- PMID 29139533.
- PMID 7474221.
- PMID 16702348.
- PMID 9892328.
- PMID 11411265.
- S2CID 29977127.
- ^ a b c d e f g h "Homocysteine". www.thedoctorsdoctor.com. Archived from the original on 2008-12-05. Retrieved 2008-11-22.
- ^ a b Adëeva Nutritionals Canada > Optimal blood test values Archived 2009-05-29 at the Wayback Machine Retrieved on July 9, 2009
- ^ a b c d e f g h Derived from molar values using molar massof 135 g/mol
- ^ "Hyperhomocysteinemia - Hematology and Oncology - Merck Manuals Professional Edition". merckmanuals.com. Archived from the original on 2017-06-09.
- S2CID 13228673.
- S2CID 20443022.
- S2CID 7689901.
- PMID 20838622.
- PMID 22270909.
- S2CID 22853996.
- PMID 15141041.
- PMID 11145936.
- PMID 18056804.
- S2CID 45945199.
- PMID 25590290.
External links
- Homocysteine MS Spectrum
- Homocysteine at Lab Tests Online
- Homocysteine: analyte monograph[permanent dead link] - The Association for Clinical Biochemistry and Laboratory Medicine
- Prof. David Spence on homocysteine levels, kidney damage, and cardiovascular disease, The Health Report, Radio National, 24 May 2010